+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Conjugate Vaccine"

From
Conjugate Vaccines - Global Strategic Business Report - Product Thumbnail Image

Conjugate Vaccines - Global Strategic Business Report

  • Report
  • April 2025
  • 271 Pages
  • Global
From
Conjugate Vaccine Market Report 2025 - Product Thumbnail Image

Conjugate Vaccine Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
Meningococcal Vaccines - Global Strategic Business Report - Product Thumbnail Image

Meningococcal Vaccines - Global Strategic Business Report

  • Report
  • April 2025
  • 194 Pages
  • Global
From
Pneumococcal Vaccines - Global Stategic Business Report - Product Thumbnail Image

Pneumococcal Vaccines - Global Stategic Business Report

  • Report
  • April 2025
  • 72 Pages
  • Global
From
From
From
Multivalent Vaccines Market Report 2025 - Product Thumbnail Image

Multivalent Vaccines Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Loading Indicator

The Conjugate Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Conjugate Vaccines are a type of vaccine that combines a polysaccharide antigen with a protein carrier, which helps the body to recognize the antigen and mount an immune response. These vaccines are used to protect against a variety of bacterial infections, including meningitis, pneumonia, and sepsis. Conjugate Vaccines are typically administered to infants and young children, as their immune systems are not yet fully developed and are more susceptible to certain infections. In addition, these vaccines are often used in combination with other vaccines to provide broader protection against multiple diseases. Notable companies in the Conjugate Vaccine market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more